Medtronic received FDA clearance and will begin making available in the U.S. its new Aquamantys3 BSC 9.1S Bipolar Sealer with Cutting, a device that performs haemostatic sealing and coagulation of soft tissue and bone, and allows the surgeon to use it as a cutting instrument as well.
By bringing two tools into one, Medtronic hopes to save time during surgery while minimizing blood loss. Not having to switch between instruments while the blood is flowing can save seconds that are particularly important.
From the announcement:
Like other devices in the Aquamantys line, the BSC 9.1S uses Transcollation® technology, a combination of radiofrequency energy and saline that has been shown to reduce blood loss and maintain patient hemoglobin levels when used during orthopaedic procedures. Reductions in blood loss during surgery have been linked to reduced blood transfusion rates and decreased hospital length of stay.
“The BSC 9.1S combining cutting and Transcollation into a single device could simplify workflow by reducing the number of tool changes and therefore may result in a time savings for the surgeon,” said Dr. Roger Emerson, a surgeon at Presbyterian Hospital, Baylor Regional Medical Center at Plano Joint Replacement Center.
Press release: Medtronic Announces 510(k) Clearance of Bipolar Sealer with Cutting for Orthopaedic Surgery…
